Kazia Therapeutics (KZIA) Short Interest Ratio & Short Volume $3.43 -0.11 (-3.11%) Closing price 03:51 PM EasternExtended Trading$3.49 +0.06 (+1.72%) As of 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Kazia Therapeutics Short Interest DataKazia Therapeutics (KZIA) has a short interest of 19,200 shares. This marks a 44.36% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.4, indicating that it would take 0.4 days of the average trading volume of 174,339 shares to cover all short positions.Current Short Interest19,200 sharesPrevious Short Interest13,300 sharesChange Vs. Previous Month+44.36%Dollar Volume Sold Short$68,928.00Short Interest Ratio0.4 Days to CoverLast Record DateApril 30, 2025Outstanding Shares1,007,000 sharesPercentage of Shares Shorted1.91%Today's Trading Volume9,696 sharesAverage Trading Volume174,339 sharesToday's Volume Vs. Average6% Short Selling Kazia Therapeutics? Sign up to receive the latest short interest report for Kazia Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartKZIA Short Interest Over TimeKZIA Days to Cover Over TimeKZIA Percentage of Float Shorted Over Time Kazia Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202519,200 shares $68,928.00 +44.4%N/A0.4 $3.59 4/15/202513,300 shares $48,219.15 -83.6%0.3%0 $3.63 3/31/202581,200 shares $63,571.48 -29.9%1.6%0 $0.78 3/15/2025115,900 shares $115,343.68 +94.5%2.3%0.1 $1.00 2/28/202559,600 shares $50,743.44 -34.1%2.1%0 $0.85 2/15/202590,500 shares $80,545.00 -90.2%3.1%0.1 $0.89 1/31/2025921,900 shares $1.46 million +7,712.7%31.7%0.5 $1.58 1/15/202511,800 shares $18,290.00 +110.7%0.4%0.1 $1.55 12/31/20245,600 shares $9,912.00 -66.7%N/A0 $1.77 12/15/202416,800 shares $59,640.00 -24.7%N/A0.1 $3.55 Get the Latest News and Ratings for KZIA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Kazia Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/30/202422,300 shares $115,291.00 -36.3%N/A0.2 $5.17 11/15/202435,000 shares $159,950.00 +86.2%N/A0.2 $4.57 10/31/202418,800 shares $101,520.00 -88.5%N/A0.1 $5.40 10/15/2024164,000 shares $54,136.40 -47.4%N/A0.1 $0.33 9/30/2024311,600 shares $133,956.84 -80.5%N/A0 $0.43 9/15/20241,600,000 shares $548,960.00 +388.1%N/A0.1 $0.34 8/31/2024327,800 shares $138,757.74 -21.8%N/A0 $0.42 8/15/2024418,900 shares $161,276.50 +85.0%N/A0 $0.39 7/31/2024226,400 shares $84,447.20 -93.3%N/A0 $0.37 7/15/20243,380,000 shares $1.89 million +7,076.2%N/A0.3 $0.56 6/30/202447,100 shares $10,767.06 +97.9%N/A0 $0.23 6/15/202423,800 shares $5,475.55 -10.2%N/A0.1 $0.23 5/31/202426,500 shares $6,890.00 -45.0%N/A0.1 $0.26 5/15/202448,200 shares $13,009.18 -44.0%N/A0.1 $0.27 4/30/202486,000 shares $28,792.80 +367.4%N/A0.1 $0.33 4/15/202418,400 shares $5,648.80 -92.9%N/A0 $0.31 3/31/2024259,500 shares $80,393.10 +6.9%N/A0.3 $0.31 3/15/2024242,800 shares $54,362.92 -68.3%N/A0.3 $0.22 2/29/2024765,100 shares $195,177.01 +1,566.9%N/A1.1 $0.26 2/15/202445,900 shares $14,242.77 -74.7%N/A0.1 $0.31 1/31/2024181,700 shares $54,328.30 +54.5%N/A1 $0.30 1/15/2024117,600 shares $41,148.24 +103.1%N/A1.1 $0.35 12/31/202357,900 shares $25,447.05 +32.8%N/A0.6 $0.44 12/15/202343,600 shares $17,047.60 -40.3%N/A0.5 $0.39 11/30/202373,000 shares $40,931.10 -35.6%N/A0.9 $0.56 11/15/2023113,400 shares $87,658.20 +1,889.5%N/A1.6 $0.77 10/31/20235,700 shares $2,393.43 -95.0%N/A0.1 $0.42 10/15/2023113,800 shares $77,384.00 +116.8%N/A3.1 $0.68 9/30/202352,500 shares $52,250.63 +10.3%N/A1.3 $1.00 9/15/202347,600 shares $48,076.00 -24.3%N/A0.3 $1.01Musk’s Project Colossus could mint millionaires (Ad)I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.All the details are waiting for you now — but you need to act before the May 1st funding window clos 8/31/202362,900 shares $57,245.29 +10.5%N/A0.3 $0.91 8/15/202356,900 shares $51,329.49 -33.5%N/A0.3 $0.90 7/31/202385,600 shares $86,456.00 -2.5%N/A0.5 $1.01 7/15/202387,800 shares $76,745.98 -36.8%N/A0.5 $0.87 6/30/2023139,000 shares $158,460.00 -3.6%N/A0.8 $1.14 6/15/2023144,200 shares $181,692.00 -10.7%N/A4.7 $1.26 5/31/2023161,500 shares $192,185.00 +20.3%N/A4.8 $1.19 5/15/2023134,300 shares $178,619.00 -24.4%N/A3 $1.33 4/30/2023177,700 shares $236,341.00 +28.2%N/A3.9 $1.33 4/15/2023138,600 shares $182,952.00 -2.0%N/A2.8 $1.32 3/31/2023141,400 shares $145,656.14 +10.0%N/A2.7 $1.03 3/15/2023128,600 shares $120,768.26 -8.5%N/A2.2 $0.94 2/28/2023140,600 shares $129,352.00 -3.8%N/A2.3 $0.92 2/15/2023146,100 shares $131,490.00 -17.3%N/A2.6 $0.90 1/31/2023176,700 shares $182,001.00 -28.5%N/A2.8 $1.03 1/15/2023247,100 shares $259,455.00 +64.2%N/A0.7 $1.05 12/30/2022150,500 shares $92,542.45 -7.8%N/A0.4 $0.61 12/15/2022163,300 shares $89,145.47 -6.1%N/A0.5 $0.55 11/30/2022173,900 shares $104,966.04 -3.4%N/A0.5 $0.60 11/15/2022180,100 shares $118,866.00 -75.8%N/A0.5 $0.66 10/31/2022744,000 shares $614,767.20 +526.3%N/A2.1 $0.83 10/15/2022118,800 shares $118,800.00 +7.1%N/A0.4 $1.00 9/30/2022110,900 shares $121,990.00 -5.9%N/A0.4 $1.10 9/15/2022117,900 shares $168,597.00 -20.7%N/A0.3 $1.43 8/31/2022148,700 shares $227,511.00 -24.8%N/A0.2 $1.53 8/15/2022197,700 shares $345,975.00 +68.7%N/A0.3 $1.75 7/31/2022117,200 shares $425,436.00 -19.0%N/A0.2 $3.63 7/15/2022144,600 shares $539,358.00 +113.9%N/A0.4 $3.73 6/30/202267,600 shares $283,920.00 +90.4%N/A0.2 $4.20 6/15/202235,500 shares $191,700.00 +86.8%N/A0.1 $5.40 5/31/202219,000 shares $110,010.00 -21.2%N/A0.7 $5.79 5/15/202224,100 shares $132,309.00 +225.7%N/A1.2 $5.49 4/30/20227,400 shares $47,582.00 -53.5%N/A0.5 $6.43 4/15/202215,900 shares $121,317.00 +45.9%N/A1.2 $7.63 3/31/202210,900 shares $84,039.00 +445.0%N/A0.7 $7.71 3/15/20222,000 shares $12,100.00 -79.4%N/A0.1 $6.05 2/28/20229,700 shares $65,184.00 +592.9%N/A0.5 $6.72 2/15/20221,400 shares $10,514.00 +55.6%N/A0.1 $7.51 1/31/2022900 shares $6,030.00 -64.0%N/A0 $6.70 1/15/20222,500 shares $19,500.00 -19.4%N/A0.1 $7.80 12/31/20213,100 shares $26,102.00 -59.2%N/A0.1 $8.42 12/15/20217,600 shares $55,860.00 +20.6%N/A0.3 $7.35 11/30/20216,300 shares $63,189.00 +162.5%N/A0.2 $10.03 11/15/20212,400 shares $26,856.00 +4.4%N/A0.1 $11.19 10/29/20212,300 shares $24,909.00 -37.8%N/A0.1 $10.83 10/15/20213,700 shares $38,850.00 -67.8%N/A0.1 $10.50 9/30/202111,500 shares $130,180.00 -27.7%N/A0.5 $11.32 9/15/202115,900 shares $165,042.00 -29.0%N/A0.6 $10.38 8/31/202122,400 shares $243,040.00 +21.7%N/A0.7 $10.85 8/13/202118,400 shares $174,800.00 -18.6%N/A0.6 $9.50Musk’s Project Colossus could mint millionaires (Ad)I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.All the details are waiting for you now — but you need to act before the May 1st funding window clos 7/30/202122,600 shares $204,078.00 -3.0%N/A0.6 $9.03 7/15/202123,300 shares $223,214.00 -16.5%N/A0.6 $9.58 6/30/202127,900 shares $275,094.00 +57.6%N/A0.5 $9.86 6/15/202117,700 shares $189,921.00 -18.1%N/A0.2 $10.73 5/28/202121,600 shares $205,416.00 -14.3%N/A0.2 $9.51 5/14/202125,200 shares $239,904.00 -38.2%N/A0.2 $9.52 4/30/202140,800 shares $444,720.00 +1,175.0%N/A0.3 $10.90 4/15/20213,200 shares $36,544.00 -88.5%N/A0 $11.42 3/31/202127,700 shares $333,508.00 -27.1%N/A0.2 $12.04 3/15/202138,000 shares $417,240.00 +32.9%N/A0.3 $10.98 2/26/202128,600 shares $297,154.00 +236.5%N/A0.2 $10.39 2/12/20218,500 shares $85,850.00 -18.3%N/A0 $10.10 1/29/202110,400 shares $99,424.00 -35.0%N/A0 $9.56 1/15/202116,000 shares $164,640.00 No ChangeN/A0 $10.29 KZIA Short Interest - Frequently Asked Questions What is Kazia Therapeutics' current short interest? Short interest is the volume of Kazia Therapeutics shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 19,200 shares of KZIA short. Learn More on Kazia Therapeutics' current short interest. Is Kazia Therapeutics' short interest increasing or decreasing? Kazia Therapeutics saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 19,200 shares, an increase of 44.4% from the previous total of 13,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Kazia Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Kazia Therapeutics: GeoVax Labs, Inc. (5.89%), Equillium, Inc. (0.81%), Edesa Biotech, Inc. (0.68%), Leap Therapeutics, Inc. (7.19%), MEI Pharma, Inc. (0.03%), ProPhase Labs, Inc. (1.09%), 23andMe Holding Co. (11.90%), Relmada Therapeutics, Inc. (6.12%), Trinity Biotech plc (0.92%), Synlogic, Inc. (0.44%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Spotify Technology S.A. ($4.67 billion), Charter Communications, Inc. ($4.58 billion), Capital One Financial Co. ($4.47 billion), The Kroger Co. ($2.56 billion), Reddit, Inc. ($2.23 billion), Rivian Automotive, Inc. ($2.16 billion), Live Nation Entertainment, Inc. ($1.90 billion), SoFi Technologies, Inc. ($1.85 billion), Zscaler, Inc. ($1.75 billion), and Omnicom Group Inc. ($1.75 billion). View all of the most shorted stocks. What does it mean to sell short Kazia Therapeutics stock? Short selling KZIA is an investing strategy that aims to generate trading profit from Kazia Therapeutics as its price is falling. KZIA shares are trading down $0.11 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Kazia Therapeutics? A short squeeze for Kazia Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of KZIA, which in turn drives the price of the stock up even further. How often is Kazia Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including KZIA, twice per month. The most recent reporting period available is April, 30 2025. More Short Interest Resources from MarketBeat Related Companies GOVX Short Squeeze EQ Short Squeeze EDSA Short Squeeze LPTX Short Squeeze MEIP Short Squeeze PRPH Short Squeeze ME Short Squeeze RLMD Short Squeeze TRIB Short Squeeze SYBX Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:KZIA) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kazia Therapeutics Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Kazia Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy KZIA Stock Free KZIA Stock Alerts